UB Paderborn / Katalog / Suche / in CDI

1 – 17 von 17

Sortiert nach

MYD88 mutations identify a molecular subgroup of diffuse large B-cell lymphoma with an unfavorable prognosis

Haematologica (Roma), 2020-02, Vol.105 (2), p.424-434

2020

Link zum Volltext

Verfügbarkeit prüfen

Megadose Methylprednisolone (MDMP) Treatment in a Patient with Autoimmune Hemolytic Anemia (AIHA) Resistant to Conventional Corticosteroid Administration: A Case Report

Turkish journal of haematology, 2013-06, Vol.30 (2), p.194-197

2013

Link zum Volltext

Verfügbarkeit prüfen

Cyclophosphamide, doxorubicin, vincristine and prednisone chemotherapy and radiotherapy for stage I intermediate or high grade non-Hodgkin's lymphomas: results of a strategy that adapts radiotherapy dose to the response after chemotherapy

Radiotherapy and oncology, 2001-03, Vol.58 (3), p.251-255

2001

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of subcutaneous and intravenous rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone in first-line diffuse large B-cell lymphoma: the randomized MabEase study

Haematologica (Roma), 2017-11, Vol.102 (11), p.1913-1922

2017

Link zum Volltext

Verfügbarkeit prüfen

Measurement of total homocysteine concentrations in acidic citrate- and EDTA-containing tubes by different methods

Clinical chemistry (Baltimore, Md.), 2004-10, Vol.50 (10), p.1881-1883

2004

Link zum Volltext

Verfügbarkeit prüfen

First Report on a Successful Screening Program for MYC Rearrangements and a Prospective Clinical Trial Based on MYC Rearrangement in Newly Diagnosed DLBCL Patients in the Netherlands

Blood, 2017-12, Vol.130, p.4144-4144

2017

Link zum Volltext

Verfügbarkeit prüfen

Bortezomib Maintenance Therapy after Induction with R-CHOP, ARA-C and Autologous Stem Cell Transplantation in Newly Diagnosed MCL Patients, Results of a Multicenter Phase II HOVON Study

Blood, 2015-12, Vol.126 (23), p.339-339

2015

Link zum Volltext

Verfügbarkeit prüfen

Megadose methylprednisolone resistant to conventional corticosteroid administration: a case report / Konvansiyonel Kortikosteroid Uygulamasina Resiztan Otoimmun Hemolitik Anemili Bir Hastanin Megadoz Metilprednizolonla Tedavisi

Turkish journal of haematology, 2013-06, Vol.30 (2), p.194

2013

Link zum Volltext

Verfügbarkeit prüfen

Megadose Methylprednisolone (MDMP) Treatment in a Patient with Autoimmune Hemolytic Anemia (AIHA) Resistant to Conventional Corticosteroid Administration: A Case Report/Konvansiyonel Kortikosteroid Uygulamasina Resiztan Otoimmün Hemolitik Anemili Bir Hastanin Megadoz Metilprednizolonla Tedavisi

Turkish journal of haematology, 2013-06, Vol.30 (2), p.194

2013

Link zum Volltext

Verfügbarkeit prüfen

Rituximab-PECC Induction Followed by 90y-Ibritumomab Tiuxetan Consolidation in Relapsed or Refractory DLBCL Patients Who Are Not Eligible for or After ASCT: Preliminary Results From a Phase II HOVON Study

Blood, 2012-11, Vol.120 (21), p.2729-2729

2012

Link zum Volltext

Verfügbarkeit prüfen

A woman with low hemoglobin values

Nederlands tijdschrift voor geneeskunde, 2010, Vol.154, p.A1035

2010

Link zum Volltext

Verfügbarkeit prüfen

1 – 17 von 17

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(16)
Mit Volltextzugriff
(16)

Publikationsform

Artikel
(17)

Sprache

Englisch
(16)
Niederländisch
(1)

Erscheinungsjahr

n.n

Thema

Humans
(6)
Life Sciences & Biomedicine
(6)
Science & Technology
(6)
Female
(5)
Hematology
(5)
Middle Aged
(5)
Adult
(4)
Aged
(4)
Male
(4)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(3)
Aged, 80 And Over
(2)
Doxorubicin - Administration & Dosage
(2)
Neoplasm Staging
(2)
Prognosis
(2)
Survival Rate
(2)
Treatment Outcome
(2)
90y‐ibritumomab Tiuxetan
(1)
Administration, Intravenous
(1)
Adolescent
(1)
Antibodies, Monoclonal, Murine-Derived - Adverse Effects
(1)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Blood
(6)
Turkish Journal Of Haematology
(3)
British Journal Of Haematology
(2)
Haematologica
(2)
Clinical Chemistry
(1)
Journal Of Clinical Oncology
(1)
Nederlands Tijdschrift Voor Geneeskunde
(1)
Radiotherapy And Oncology
(1)

3 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

MYD88 mutations identify a molecular subgroup of diffuse large B-cell lymphoma with an unfavorable prognosis

A randomized phase 3 study on the effect of thalidomide combined with adriamycin, dexamethasone, and high-dose melphalan, followed by thalidomide maintenance in patients with multiple myeloma

Rituximab‐PECC induction followed by 90Y‐ibritumomab tiuxetan consolidation in relapsed or refractory DLBCL patients who are ineligible for or have failed ASCT: results from a phase II HOVON study

Rituximab-PECC induction followed by 90 Y-ibritumomab tiuxetan consolidation in relapsed or refractory DLBCL patients who are ineligible for or have failed ASCT: results from a phase II HOVON study

Megadose Methylprednisolone (MDMP) Treatment in a Patient with Autoimmune Hemolytic Anemia (AIHA) Resistant to Conventional Corticosteroid Administration: A Case Report

Cyclophosphamide, doxorubicin, vincristine and prednisone chemotherapy and radiotherapy for stage I intermediate or high grade non-Hodgkin's lymphomas: results of a strategy that adapts radiotherapy dose to the response after chemotherapy

Efficacy and safety of subcutaneous and intravenous rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone in first-line diffuse large B-cell lymphoma: the randomized MabEase study

Measurement of total homocysteine concentrations in acidic citrate- and EDTA-containing tubes by different methods

First Report on a Successful Screening Program for MYC Rearrangements and a Prospective Clinical Trial Based on MYC Rearrangement in Newly Diagnosed DLBCL Patients in the Netherlands

Bortezomib Maintenance Therapy after Induction with R-CHOP, ARA-C and Autologous Stem Cell Transplantation in Newly Diagnosed MCL Patients, Results of a Multicenter Phase II HOVON Study

Randomized phase III study on the effect of early intensification of rituximab in combination with 2-weekly CHOP chemotherapy followed by rituximab or no maintenance in patients with diffuse large B-cell lymphoma: Results from a HOVON-Nordic Lymphoma Group study

Rituximab-Pecc Induction Followed By 90y-Ibritumomab Tiuxetan Consolidation in Relapsed or Refractory DLBCL Patients Who Are Not Eligible for or Have Failed ASCT: Results from a Phase II HOVON Study

Megadose methylprednisolone resistant to conventional corticosteroid administration: a case report / Konvansiyonel Kortikosteroid Uygulamasina Resiztan Otoimmun Hemolitik Anemili Bir Hastanin Megadoz Metilprednizolonla Tedavisi

Megadose Methylprednisolone (MDMP) Treatment in a Patient with Autoimmune Hemolytic Anemia (AIHA) Resistant to Conventional Corticosteroid Administration: A Case Report/Konvansiyonel Kortikosteroid Uygulamasina Resiztan Otoimmün Hemolitik Anemili Bir Hastanin Megadoz Metilprednizolonla Tedavisi

Rituximab-PECC Induction Followed by 90y-Ibritumomab Tiuxetan Consolidation in Relapsed or Refractory DLBCL Patients Who Are Not Eligible for or After ASCT: Preliminary Results From a Phase II HOVON Study

Final Analysis of HOVON-50 Randomized Phase III Study on the Effect of Thalidomide Combined with Adriamycine, Dexamethasone (AD) and High Dose Melphalan (HDM) in Patients with Multiple Myeloma (MM)

A woman with low hemoglobin values

Suchergebnisse filtern